JAHA:血栓闭塞性脉管炎的远期预后及影响因素

2018-12-01 MedSci MedSci原创

目前,尚缺乏血栓闭塞性脉管炎的远期预后资料,本研究的目的旨在评估血栓闭塞性脉管炎的远期预后和影响预后的因素。本研究纳入分析了224名血栓闭塞性脉管炎患者,并对血管事件和截肢相关危险因素进行了分析。患者的平均诊断年龄为38.5 (32–46)岁,女性占23.8%,白种人占81.7%。经过平均5.7年时间的随访,有58.9%的患者发生血管疾病,21.4%的患者接受了截肢,1.4%的患者死亡。无血管疾病

目前,尚缺乏血栓闭塞性脉管炎的远期预后资料,本研究的目的旨在评估血栓闭塞性脉管炎的远期预后和影响预后的因素。

本研究纳入分析了224名血栓闭塞性脉管炎患者,并对血管事件和截肢相关危险因素进行了分析。患者的平均诊断年龄为38.5 (32–46)岁,女性占23.8%,白种人占81.7%。经过平均5.7年时间的随访,有58.9%的患者发生血管疾病,21.4%的患者接受了截肢,1.4%的患者死亡。无血管疾病的生存率的独立预测因素有非白种人(HR:2.35 [1.30–4.27] P=0.005)和四肢感染(HR:3.29 [1.02–10.6] P=0.045),与截肢相关的因素为肢体感染(HR:12.1 [3.5–42.1], P<0.001)。另外,戒烟的患者截肢风险较没有戒烟的更低(P=0.001)。

研究结果显示,血栓闭塞性脉管炎有34%的患者会在诊断后的15年内发生截肢事件。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1984380, encodeId=3e6f1984380ae, content=<a href='/topic/show?id=c4bb9443038' target=_blank style='color:#2F92EE;'>#远期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94430, encryptionId=c4bb9443038, topicName=远期预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Dec 20 15:30:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267997, encodeId=51af126e99706, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465581, encodeId=c31e146558121, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=354206, encodeId=47303542063b, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Dec 01 21:44:49 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1984380, encodeId=3e6f1984380ae, content=<a href='/topic/show?id=c4bb9443038' target=_blank style='color:#2F92EE;'>#远期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94430, encryptionId=c4bb9443038, topicName=远期预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Dec 20 15:30:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267997, encodeId=51af126e99706, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465581, encodeId=c31e146558121, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=354206, encodeId=47303542063b, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Dec 01 21:44:49 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
    2018-12-03 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1984380, encodeId=3e6f1984380ae, content=<a href='/topic/show?id=c4bb9443038' target=_blank style='color:#2F92EE;'>#远期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94430, encryptionId=c4bb9443038, topicName=远期预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Dec 20 15:30:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267997, encodeId=51af126e99706, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465581, encodeId=c31e146558121, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=354206, encodeId=47303542063b, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Dec 01 21:44:49 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1984380, encodeId=3e6f1984380ae, content=<a href='/topic/show?id=c4bb9443038' target=_blank style='color:#2F92EE;'>#远期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94430, encryptionId=c4bb9443038, topicName=远期预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Thu Dec 20 15:30:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267997, encodeId=51af126e99706, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465581, encodeId=c31e146558121, content=<a href='/topic/show?id=144f5032688' target=_blank style='color:#2F92EE;'>#影响因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50326, encryptionId=144f5032688, topicName=影响因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a06745918, createdName=chenzhuanggui, createdTime=Mon Dec 03 12:30:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=354206, encodeId=47303542063b, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat Dec 01 21:44:49 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
    2018-12-01 天地飞扬

    了解一下,谢谢分享!

    0

相关资讯

盘点:JACC十一月第四期研究一览

1.NT-proBNP指导下的心衰治疗花费更多且无益处DOI: 10.1016/j.jacc.2018.08.2184http://www.onlinejacc.org/content/72/21/2551GUIDE-IT临床试验比较了N-末端B型利钠肽(NT-proBNP)指导下的心衰治疗和单纯的内科治疗在高风险心衰患者中的效果,但该研究因无明显作用而被提前终止。本研究的目的旨在评估GUID

JAHA:房颤负荷与活动量呈负相关性

近期有研究显示房颤患者的活动量与心血管死亡和发病风险呈相关性。本研究的目的旨在评估房颤的日负荷对接受肺静脉隔离患者活动量的影响。本研究纳入了DISCERN AF临床研究中的对象,所有对象均有心脏监测仪记录每天的房性心动过速和房颤(AT/AF)与相应的活动量水平。最终纳入分析了50例患者,每例患者平均有887次记录。结果显示,消融后的每日AT/AF范围为0-1440min,每日活动量的最小时间和最大

JACC:Brugada 综合征患者常同时存在结构和电生理的异常

Brugada 综合征(Brs)结构畸形的发病率和临床特点尚不清楚。本研究的目的旨在探究Brs患者的遗传背景、电解剖异常和病理基础间的相关性。剖学单极和双极性标测指导下的右室流出道心内膜心肌的活检,并对所有的患者进行了遗传学分析。结果发现,在93%的单极检测患者和50%双极检测患者中检测出了低电压区域(LVAs),且单极的LVAs往往大于双极检测的。10例患者中检测出了致病性的基因突变,在75%的

JACC:FFR指导下的冠脉搭桥预后和血管造影指导下的比较

分数流量储备(FFR)在评估冠脉搭桥术中的冠脉狭窄的作用尚不清楚,本研究的目的旨在比较和评估FFR指导下的冠脉搭桥术和血管造影指导下的冠脉搭桥术的临床预后。本研究纳入分析了100例冠脉搭桥的患者,随机分至FFR指导组和血管造影组,主要终点事件是术后6个月移植失败的百分比。术后6个月,共有72名患者的冠脉血管造影资料是完整的,FFR指导组有39名,血管造影组的有33名。分析结果发现,移植失败率在两组

JACC:经导管肺动脉瓣置换术后的心内膜炎

心内膜炎已逐渐成为先天性右室流出道疾病和假体瓣膜疾病的主要不良并发症之一。本研究的目的旨在评估肺动脉瓣置换术后心内膜炎的发生率和潜在危险因素。本研究纳入分析了309例接受经导管肺动脉瓣置换术(TPVR)的患者,经过平均5.1年时间的随访,有46例患者被诊断为心内膜炎,有35例患者报道有肺动脉瓣置换相关性心内膜炎,心内膜炎的年度化发病率为3.1%每人年,而肺动脉瓣置换相关性心内膜炎为2.4%每人年。

山东省发布分市心血管健康指数

从山东省卫健委获悉,近日,山东省卫生健康委员会、中国心血管健康联盟、中国疾病预防控制中心慢病中心联合在济南召开山东省心血管疾病防治工作座谈会。中国心血管健康联盟主席、中国科学院院士葛均波发布山东省17市心血管健康指数研究结果,山东省卫生健康委员会副主任、党组成员秦成勇做关于山东省心血管疾病防治策略的主旨讲话。